Updated Jun 2, 2026
Upgrade to a paid plan to see AI rating history on the chart.
Amgen (NASDAQ:AMGN) today announced the presentation of new data across rare autoimmune and inflammatory diseases at the European Alliance of Associations for…
Investors may want to keep an eye on June 3 as Quantinuum is set to price its IPO and make a big move toward its Wall Street debut.
As Legend’s LB2102 trial in SCLC fails to dazzle, co-developer Novartis banks on quick manufacturing to find a commercial edge.
AMGN wins EU approval for Imdylltra in extensive-stage small cell lung cancer after phase III data showed a 40% reduction in death risk.
We recently compiled a list of the 10 Popular Penny Stocks on Robinhood to Watch in 2026. TScan Therapeutics, Inc. (NASDAQ:TCRX) is one of the most popular pen…
Gilead Sciences has outperformed other healthcare stocks, and analysts remain highly optimistic about the stock’s outlook
The group has been funding research projects, touring factories and piloting workforce development programs. Its three co-directors shared highlights during re…
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear…
Not investment advice. Past performance does not guarantee future results. Full disclaimer